# Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** PAR-25-051
- **Status:** posted
- **Opens:** September 25, 2024
- **Closes:** August 18, 2026
- **CFDA:** 93.121, 93.867, 93.279, 93.853, 93.242, 93.273, 93.213, 93.866
- **View on Kontrakk:** https://kontrakk.com/grants/356531

## Description

No description provided.